Effect of Nosocomial Bloodstream Infection on the Outcome of Critically Ill Patients with Acute Renal Failure Treated with Renal Replacement Therapy

Journal of the American Society of Nephrology

Volumn 15, Issue 2, 2004, Pages 454-462

  Hoste, Eric A J ^a   Blot, Stijn I ^a   Lameire, Norbert H ^a   Vanholder, Raymond C ^a   De Bacquer, Dirk ^a   Colardyn, Francis A ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BACTEREMIA; COHORT ANALYSIS; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE COURSE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMODIALYSIS; HOSPITAL COST; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION SENSITIVITY; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

EID: 0942298014     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000110182.14608.0C     Document Type: Article

References (43)

1. Neveu H, Kleinknecht D, Brivet F, Loirat P, Landais P, the French Study Group on Acute Renal Failure: Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. Nephrol Dial Transplant 11: 293-299, 1996
2. Cole L, Bellomo R, Silvester W, Reeves JH: A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a "closed" ICU system. Am J Respir Crit Care Med 162: 191-196, 2000
3. Guerin C, Girard R, Selli JM, Perdrix JP, Ayzac L: Initial versus delayed acute renal failure in the intensive care unit. A multicenter prospective epidemiological study. Rhone-Alpes Area Study Group on Acute Renal Failure. Am J Respir Crit Care Med 161: 872-879, 2000
4. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effect of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 356: 26-30, 2000
5. Mehta RL, McDonald B, Gabbai FB, Pahl M, Pascual MTA, Farkas A, Kaplan RM, for the Collaborative Group for the Treatment of ARF in the ICU: A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 60: 1154-1163, 2001
6. Guerin C, Girard R, Selli JM, Ayzac L: Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: Results from a multicenter prospective epidemiological survey. Intensive Care Med 28: 1411-1418, 2002
7. Schiffl H, Lang SM, Fischer R: Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346: 305-310, 2002
8. Hoste E, Lameire N, Vanholder R, Benoit D, Decruyenaere M, Colardyn F: Acute renal failure in patients with sepsis in a surgical ICU: Predictive factors, incidence, comorbidity and outcome. J Am Soc Nephrol 14: 1022-1030, 2003
9. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP: Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clin Infect Dis 29: 239-244, 1999
10. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348: 138-150, 2003
11. Vanholder R, Ringoir S: Infectious morbidity and defects of phagocytic function in end-stage renal disease: A review. J Am Soc Nephrol 3: 1541-1554, 1993
12. Vanholder R, Van Biesen W: Incidence of infectious morbidity and mortality in dialysis patients. Blood Purif 20: 477-480, 2002
13. Liu JW, Su YK, Liu CF, Chen JB: Nosocomial blood-stream infection in patients with end-stage renal disease: Excess length of hospital stay, extra cost and attributable mortality. J Hosp Infect 50: 224-227, 2002
14. Burdmann EA, Yu L: Metabolic and electrolyte disturbances: Secondary manifestations. In: Acute Renal Failure. A Companion to Brenner & Rector's The Kidney, 1st ed, edited by Finn WF, Philadelphia, W.B. Saunders Company, 2001, pp 169-191
15. Hoste EA, Vanholder RC, Lameire NH, Roosens CD, Decruyenaere JM, Blot SI, Colardyn FA: No early respiratory benefit with CVVHDF in patients with acute renal failure and acute lung injury. Nephrol Dial Transplant 17: 2153-2158, 2002
16. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Disk Susceptibiblity Tests. In: National Committee for Clinical Laboratory Standards, Villanova, PA, National Committee for Clinical Laboratory Standards, 1993
17. Blot S, Vandewoude K, De Bacquer D, Colardyn F: Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: Clinical outcome and length of hospitalization. Clin Infect Dis 34: 1600-1606, 2002
18. Blot S, Vandewoude K, Hoste E, Colardyn F: Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosa. J Hosp Infect 53: 18-24, 2003
19. Carmeli Y, Troillet N, Karchmer AW, Samore MH: Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 159: 1127-1132, 1999
20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: A severity of disease classification system. Crit Care Med 13: 818-829, 1985
21. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA: Outcome and attributable mortality in critically III patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 162: 2229-2235, 2002
22. Blot S, Vandewoude K, Colardyn F: Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 29: 471-475, 2003
23. Blot SI, Vandewoude KH, Colardyn FA: Evaluation of outcome in critically ill patients with nosocomial enterobacter bacteremia: results of a matched cohort study. Chest 123: 1208-1213, 2003
24. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA: Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 113: 480-485, 2002
25. Blot SI, Vandewoude KH, Colardyn FA: Clinical impact of nosocomial Klebsiella bacteremia in critically ill patients. Eur J Clin Microbiol Infect Dis 21: 471-473, 2002
26. Rello J, Jubert P, Valles J, Artigas A, Rue M, Niederman MS: Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 23: 973-978, 1996
27. Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, Valles J: Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 162: 1027-1030, 2000
28. Girou E, Stephan F, Novara A, Safar M, Fagon JY: Risk factors and outcome of nosocomial infections: Results of a matched case-control study of ICU patients. Am J Respir Crit Care Med 157: 1151-1158, 1998
29. Wenzel RP: The mortality of hospital-acquired bloodstream infections: need for a new vital statistic? Int J Epidemiol 17: 225-227, 1988
30. Digiovine B, Chenoweth C, Watts C, Higgins M: The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 160: 976-981, 1999
31. Renaud B, Brun-Buisson C: Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 163: 1584-1590, 2001
32. Rello J, Ricart M, Mirelis B, Quintana E, Gurgui M, Net A, Prats G: Nosocomial bacteremia in a medical-surgical intensive care unit: Epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med 20: 94-98, 1994
33. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M: The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee Jama 274: 639-644, 1995
34. Warren DK, Zack JE, Elward AM, Cox MJ, Fraser VJ: Nosocomial primary bloodstream infections in intensive care unit patients in a nonteaching community medical center: a 21-month prospective study. Clin Infect Dis 33: 1329-1335, 2001
35. Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S: Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: A matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 20: 396-401, 1999
36. Laupland KB, Zygun DA, Davies HD, Church DL, Louie TJ, Doig CJ: Population-based assessment of intensive care unit-acquired bloodstream infections in adults: Incidence, risk factors, and associated mortality rate. Crit Care Med 30: 2462-2467, 2002
37. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH: The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118: 146-155, 2000
38. Kollef MH, Sherman G, Ward S, Fraser VJ: Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 115: 462-474, 1999
39. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD: The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244: 379-386, 1998
40. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ: Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 36: 1418-1423, 2003
41. Pittet D, Tarara D, Wenzel RP: Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271: 1598-1601, 1994
42. Smith RL, Meixler SM, Simberkoff MS: Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 100: 164-167, 1991
43. Fagon JY, Chastre J, Vuagnat A, Trouillet JL, Novara A, Gibert C: Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 275: 866-869, 1996